Asset Management One Co. Ltd. Buys 35,894 Shares of CVS Health Corporation (NYSE:CVS)

Asset Management One Co. Ltd. lifted its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 7.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 514,355 shares of the pharmacy operator's stock after purchasing an additional 35,894 shares during the period. Asset Management One Co. Ltd.'s holdings in CVS Health were worth $34,848,000 at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Hopwood Financial Services Inc. acquired a new position in shares of CVS Health during the 4th quarter valued at about $29,000. McIlrath & Eck LLC lifted its position in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares during the last quarter. Providence First Trust Co acquired a new stake in shares of CVS Health in the fourth quarter valued at about $42,000. Park Square Financial Group LLC bought a new position in shares of CVS Health in the fourth quarter worth about $43,000. Finally, PARK CIRCLE Co lifted its position in shares of CVS Health by 42.9% during the 4th quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock worth $45,000 after purchasing an additional 300 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Trading Up 2.3%

CVS traded up $1.53 during trading on Thursday, reaching $67.90. 601,891 shares of the company's stock were exchanged, compared to its average volume of 10,869,943. The company's fifty day moving average price is $64.81 and its 200-day moving average price is $60.62. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The firm has a market capitalization of $85.89 billion, a PE ratio of 16.22, a P/E/G ratio of 0.97 and a beta of 0.56. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company's revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.31 EPS. As a group, equities analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CVS. UBS Group raised their target price on CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Mizuho raised their price target on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Truist Financial raised their price objective on CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Finally, Royal Bank Of Canada increased their price objective on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $74.75.

Insider Transactions at CVS Health

In other news, Director Guy P. Sansone acquired 1,570 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the acquisition, the director now owns 12,007 shares in the company, valued at $764,845.90. This represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.22% of the stock is owned by insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.